Isothiazole ring formation with substituted 2-alkylthio-3-acyl-4-quinolinone using O-(mesitylenesulfonyl)hydroxylamine (MSH)

Synlett

Volumn , Issue 2, 2003, Pages 166-172

  Choi, Jong Hee ^a   Choi, Eun Bok ^a   Pak, Chwang Siek ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Cyclizations; Electrophilic addition; Imine; Isothiazole; O (mesitylenesulfonyl)hydroxyl amine

Indexed keywords

HYDROXYLAMINE; ISOTHIAZOLE DERIVATIVE; O (MESITYLENESULFONYL)HYDROXYLAMINE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; DEALKYLATION; DRUG STRUCTURE; DRUG SYNTHESIS; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0037284478     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-36802     Document Type: Article

References (55)

1. Komoriya, K.; Nagata, I.; Osada, Y.; Kondo, S. JP 90-183990, 1992; Chem. Abstr. 1992, 117, 104253.
2. Romeo, G.; Bousquet, E.; Pappalardo, M. S.; Ronsisvalle, G.; Oliveri, S.; Cammarata, E. Farmaco 1988, 43, 457.
3. Nagano, N.; Nakano, K.; Shibanuma, T.; Murakami, Y.; Hara, R. J. Antibiot. 1987, 40, 173.
4. (a) Cutri, C. C. C.; Garozzo, A.; Siracusa, M. A.; Castro, A.; Tempera, G.; Sarva, M. C.; Guerrera, F. Antiviral Res. 2002, 55, 357.
5. (b) Inglot, A. D.; Machon, Z.; Wolna, E.; Wilimowski, M.; Prandota, J. Arch. Immunol. Ther. Exp. 1973, 21, 891.
6. Aebi, J.; Ackermann, J.; Dehmlow, H.; Maerki, H.-P.; Morand, O. PCT Int. Appl. WO 0236584, 2002; Chem. Abstr. 2002, 136, 369719.
7. (a) Kitagawa, Y.; Ishikawa, K.; Sawada, H.; Araki, Y.; Shigyo, T.; Aszmann, L. PCT Int. Appl. WO 0177090, 2001; Chem. Abstr. 2001, 135, 318501.
8. (b) Chemla, P.; Maetzke, T.; Ertl, P. PCT Int. Appl. WO 9932464, 1999; Chem. Abstr. 1999, 131, 58832.
9. (a) Heil, M.; Bretschneider, T.; Kleefeld, G.; Erdelen, C.; Turberg, A.; Mencke, N. Ger. Often. DE 19736545, 1999; Chem. Abstr. 1999, 130, 182458.
10. (b) Cetusic, J.; Rieder, B. J. PCT Int. Appl. WO 0224691, 2002; Chem. Abstr. 2002, 136, 279447.
11. (c) Assmann, L.; Kitagawa, Y.; Ishikawa, K.; Sawada, H.; Araki, Y.; Shigyo, T. PCT Int. Appl, WO 0129014, 2001; Chem. Abstr. 2001 134, 311204
12. (d) Andersch, W.; Wachendorff-Neumann, U. PCT Int. Appl. WO 0035286, 2000; Chem. Abstr. 2000, 133, 39470.
13. (a) Rahman, L. K. A.; Scrowston, R. M. J. Chem. Soc., Perkin Trans. 1. 1983, 2973.
14. (b) Shimizu, M.; Kikumoto, H.; Konakahara, T.; Gama, Y.; Shibuya, I. Heterocycles 1999, 15, 3005.
15. (c) Chiyoda, T.; Iida, K.; Takatori, K.; Kajiwara, M. Synlett 2000, 1427.
16. (d) Zlotin, S. G.; Kislitsin, P. G.; Podgursky, A. V.; Samet, A. V.; Buchanan, A. G. III; Gakh, A. A. J. Org. Chem. 2000, 65, 8439.
17. (a) Ikuo, I.; Kenner, C. R. J. Heterocycl. Chem. 1978, 15, 1527.
18. (b) Noris, S. Chem. Pharm. Bull. 1980, 28, 761.
19. (c) Hull, R.; van den Broek, P. J.; Swain, M. L. J. Chem. Soc., Perkin Trans. 1 1975, 2271.
20. (d) Hull, R. J. Chem. Soc., Perkin Trans. 1 1973, 2911.
21. (e) Daniel, T. W. C.; Claiborne, A. K. J. Heterocycl. Chem. 1990, 27, 1191.
22. (a) Cecchetti, V.; Fravolini, A.; Fringuelli, R.; Schiaffella, F. J. Heterocycl. Chem. 1993, 30, 11431.
23. (b) Daniel, T. W. C. Claiborne, A. K. J. Heterocycl. Chem. 1990, 27, 1191.
24. (a) Dieter, R. K.; Chang, H. J. J. Org. Chem. 1989, 54, 1088.
25. (b) Laaman, S. M.; Meth-Cohn, O.; Rees, C. W. Synthesis 1999, 757.
26. (a) Iijima, I.; Rice, K. C. J. Heterocycl. Chem. 1978, 15, 1527.
27. (b) Rahman, L. K. A.; Scrowston, R. M. J. Chem. Soc., Perkin Trans. 1. 1983, 2973.
28. (a) Stumpf, M.; Hall, H. Liebigs Ann. Chem. 1994, 1049.
29. (b) Liu, K. C.; Shin, B. J.; Hu, M. K. J. Heterocycl. Chem. 1987, 24, 1729.
30. (c) Gunzenhauser, S.: Ball, H. Helv. Chim. Acta 1985, 68, 56.
31. (a) Anthony, D. M.; Curtis, R. M.; Christoper, A.; Ramsden Muhammad, R. R. Chem. Commun. 1999, 189.
32. (b) William, L. M.; Joyce, Z. Z. J. Org. Chem. 1990, 55, 5791.
33. (c) Tamura, Y.; Sumoto, K.; Minamikawa, J.; Ikeda, M. Tetrahedron Lett. 1972, 4137.
34. (a) Haga, N.; Endo, Y.; Kataoka, K.; Yamaguchi, K.; Shudo, K. J. Am. Chem. Soc. 1992, 114, 9795.
35. (b) Kagechika, H.; Himi, T.; Namikawa, K.; Kawaki, E.; Hasimoto, Y.; Shudo, K. J. Med. Chem. 1989, 32, 1098.
36. (a) Keana, J. W.; Heo, G. S.; Gaughan, G. T. J. Org. Chem. 1985, 50, 2346.
37. (b) Luh, T. Y.; Chow, H. F.; Leung, W. Y.; Tam, S. W. Tetrahedron 1985, 41, 519.
38. (a) Chenault, J.; Plisson, C.; Treillard, P.; Buisson, Y.; Edmont, D. Synth. Commun. 2000, 30, 217.
39. (b) Aoki, M.; Kamata, M.; Ohtsuka, T.; Shimma, N.; Yokose, K. Eur. Pat. Appl. 259804, 1988; Chem. Abstr. 1988, 109, 73478.
40. (c) Wentland, M. P.; Balley, D. M. Eur. Pat.Appl. 90424, 1983; Chem. Abstr. 1984, 100, 138969.
41. X-ray crystal structure analysis of 2a and 3f: Atomic coordinates, bond lengths [Å] and angles [deg], anisotropic displacement parameters, hydrogen coordinates, torsion angles [deg] have been deposited at Cambridge Crystallographic Data Centre 12, Union Road. Cambridge. CB2 1EZ, UK. Under deposition number CCDC 192773 for 2a,CCDC 192772 for 3f (Fax: +44(1223)336033, E-mail:deposit@ccdc.cam.ac.uk).
42. +), 196, 182, 174, 165, 149.
43. th run 3 h, 1 d, 3 d interval spectrum was obtained.
44. 2Me, 3.47 min MeOH.
45. Guthrie, J. P. J. Am. Chem. Soc. 1974, 96. 3608.
46. Johnson, C. R.; Corkins, H. G. J. Org. Chem. 1978, 43, 4136.
47. (a) Segawa, J.; Kitano, M.; Kazuno, K.; Matsuoka, M.; Shirahase, I.; Ozaki, M.; Matsuda, M.; Tomii, Y.; Kise, M. J. Med. Chem. 1992, 35, 4727.
48. (b) Matsuoka, M.; Segawa, J.; Makita, Y.; Ohmachi, S.; Kashima, T.; Nakamura, K. I.; Hattori, M.; Kitano, M.; Kise, M. J. Heterocycl. Chem. 1997, 34, 1773.
49. Entry 1: (a) Bhat, B.; Bhaduri, A. P. Synthesis 1984, 673.
50. (b) See also: Meth-Cohn, O.; Narine, B.; Tarnowski, B. Tetrahedron Lett. 1979, 3111.
51. (c) Entry 3: Eiden, F.; Rademacher, G. Arch. Pharm. (Weinheim) 1983, 316, 34.
52. (d) Entry 4: Smith, J. G.; Dibble, P. W.; Sandborn, R. E. J. Org. Chem. 1986, 51, 3762.
53. (a) Electrophilic superdelocalizability was calculated with CacheWorkSystem version 3.2 program.
54. (b) Rogers, K. S.; Cammarata, A. J. Med. Chem. 1969, 12, 692.
55. Methylthio group of quinolinone 1a was removed by Raney nickel to provide 3-acyl-4-quinolinone (8) and acyl group of 1a was removed by treatment with trifluoro acetic acid as solvent to give 2-methylthio-4-quinolinone (9). Reaction of 8 or 9 with MSH did not proceed after overnight stirring under the same condition.